The health services industry closed the day down 1.4%. World Heart Corporation ( WHRT), Genomic Health Inc ( GHDX), Nanosphere Inc ( NSPH), and Psychemedics Corporation ( PMD) were all winners today within the health services industry with Edwards Life ( EW) being today's featured health services winner. Edwards Life rose 54 cents (0.8%) to $71.42 on average volume. Throughout the day, 1.4 million shares of Edwards Life exchanged hands as compared to its average daily volume of 1.3 million shares.

Edwards Lifesciences Corporation offers products and technologies designed to treat advanced cardiovascular disease worldwide. It provides products for heart valve therapy; critical care; cardiac surgery systems; and vascular diseases. Edwards Life has a market cap of $8.7 billion and is part of the health care sector. The company has a P/E ratio of 38.7, below the average health services industry P/E ratio of 38.9 and above the S&P 500 P/E ratio of 17.7. Shares are down 6.1% year to date as of the close of trading on Thursday.

TheStreet Ratings rates Edwards Life Sciences as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.

On the negative front, Tengion Inc ( TNGN), Kips Bay Medical Inc ( KIPS), Sun Healthcare Group Inc ( SUNH), and Concord Medical Services Holdings ( CCM) were all losers within the health services industry with Boston Scientific Inc ( BSX) being today's health services industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock